Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 24;42(24):126287.
doi: 10.1016/j.vaccine.2024.126287. Epub 2024 Sep 3.

Jurisdiction-level costs of the initial phase of the COVID-19 vaccination program in the United States, December 20, 2020-May 31, 2021

Affiliations

Jurisdiction-level costs of the initial phase of the COVID-19 vaccination program in the United States, December 20, 2020-May 31, 2021

Christine Kim et al. Vaccine. .

Abstract

This study aimed to quantify U.S. jurisdiction-level costs related to the COVID-19 Vaccination Program by estimating the per-dose-administered cost during December 20, 2020-May 31, 2021, from a combined federal and local government perspective. Costs were limited to vaccine purchase, administration (including operations and wastage), and local redistribution by jurisdictions. Data were collected through publicly available sources, published literature, and a survey of 62 jurisdictions (38 responded). A total of 284.6 million doses of COVID-19 vaccine were distributed to jurisdictions during the study period, of which 284.2 million doses were administered, and 0.4 million doses were wasted. The estimated cost per-dose-administered among the 38 jurisdictions that responded to study survey was $57.45 and imputed cost across all jurisdictions was $63.11. The findings on jurisdiction-level cost per-dose-administered and vaccination cost during the initial period of U.S. COVID-19 Vaccination Program, when demand exceeded supply, may be considered in future pandemic preparedness planning.

Keywords: COVID-19; Jurisdictions; Public health; Vaccine costs.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1.
Fig. 1.
COVID-19 vaccine distribution process in the United States, December 20, 2020–May 31, 2021. BARDA: Biomedical Advanced Research and Development Authority; HHS: Health and Human Services; IIS: Immunization Information System; VTrckS: Vaccine Tracking System. Costs associated with the orange arrows were included in this study. Costs associated with the blue arrows were not included in this study. Non-cost related data on vaccine dose shipment, administration, and wastage units along the blue and orange arrows are captured in this study. * VTrckS is CDC’s vaccine management and ordering system for publicly funded vaccines. Awardees include 62 jurisdictions, 21 federal retail pharmacy partners, 2 renal dialysis partners, and federal entities (Indian Health Services, Health Resources and Services Administration, Department of Defense, Veterans Health Administration, Department of State, Bureau of Prisons). § The IIS’s are computerized databases that record all immunization doses administered by participating providers to persons residing within a given geopolitical area. This figure was adapted from https://www.cdc.gov/flu/pdf/pandemic-resources/pandemic-influenza-vaccine-distribution-9p-508.pdf (Accessed on March 26, 2024).

References

    1. Oliver S, Gargano J, Marin M, Wallace M, Curran K, Chamberland M, et al. The Advisory Committee on Immunization Practices’ Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine — United States, December 2020. 69 MMWR Morb Mortal Wkly Rep, 69 (2020), pp. 4–1922 - PMC - PubMed
    1. FDA Takes Key Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for First COVID-19 Vaccine; FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine [press release]. FDA News Release 2020 (2020)
    1. Centers for Disease Control and Prevention. Vaccines for COVID-19 Available from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html (2024)
    1. Centers for Disease Control and Prevention. COVID-19 Vaccination Planning and Partnerships Available from https://www.cdc.gov/vaccines/covid-19/planning/index.html (2021)
    1. Kohli M, Maschio M, Becker D, Weinstein MC The potential public health and economic value of a hypothetical COVID-19 vaccine in the United States: use of cost-effectiveness modeling to inform vaccination prioritization. Vaccine, 39 (7) (2021), pp. 1157–1164 - PMC - PubMed

Publication types

Substances